Geffy 250mg Tablet

Product Description

Geffy 250mg Tablet contains Gefitinib, which is an oral medication used primarily in the treatment of non-small cell lung cancer that has specific mutations in the epidermal growth factor receptor gene. As a tyrosine kinase inhibitor, gefitinib functions by obstructing the signals that encourage the development of cancer cells.

Women undergoing treatment should use effective contraception to avoid pregnancy during and for one month after treatment, and inform their doctor about all other medications being taken.

Brand Name: Geffy

Composition: Gefitinib

Mechanism of Action:

The signaling pathways that regulate cell migration, survival, and proliferation are mediated by the EGFR tyrosine kinase, which is selectively inhibited by gefitinib. Gefitinib can stop the proliferation of cancer cells by blocking this route.

Uses:

Non-small cell lung cancer

Dosage and Administration:

250mg once daily, taken with or without food. The tablet should be swallowed whole with water. Do not crush or chew the tablet.

Side Effects:

         Rash (acne-like)

         Diarrhea

         Fatigue

         Nausea

         Vomiting

         Shortness of breath

         Bone pain

         Constipation

         Loss of appetite

         Dry skin

         Cough